Explorer
Know how is ZyCoV-D vaccine different from other
The phase II study of the vaccine ZyCoV-D had been conducted in over 1,000 healthy adult volunteers as part of the adaptive phase I/II dose escalation, multi-centric, randomised, double-blind placebo controlled study. The vaccine was found to be safe and immunogenic. Watch video to know more.
India
Twisha Sharma Case: CBI Chargesheet Says Death Was Suicide
Breaking News: Ujjain Mahakal Temple Panic After Current Rumour, Devotees Injured During Nag Panchami Rush
Breaking News: Ujjain Mahakal Crowd Panic Leaves 13 Injured Amid Current Rumour, Crowd Management Questions Rise9
Breaking: Sawan Monday Turns Tragic as Lakhisarai Stampede, Birbhum Fire and Ujjain Chaos Raise Alarm
Breaking News: NTA Faces Fresh Heat as NSUI Protests UGC NET Re-Exam, Demands Accountability
View More
Top Headlines
India
‘Students’ Demands Are Justified’: Rahul Gandhi Urges Hemant Soren To Meet Jharkhand Protestors
India
Big Relief For Rahul Gandhi As SC Asks Allahabad HC To Halt Disproportionate Assets Case Proceedings
India
Prashant Kishor Takes Oath As Bankipur MLA After Historic By-Election Win
India
Two More Air India Pilots Fail Drug Test After Phuket-Delhi Incident; Took Off-Roster
Trending News
